Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin

Rao, Devika ; Mallick, Atrayee Basu ; Augustine, Titto ; Daroqui, Cecilia ; Jiffry, Jeeshan ; Merla, Amartej ; Chaudhary, Imran ; Seetharam, Raviraja ; Sood, Arjun ; Gajavelli, Srikanth ; Aparo, Santiago ; Rajdev, Lakshmi ; Kaubisch, Andreas ; Chuy, Jennifer ; Negassa, Abdissa ; Mariadason, John M ; Maitra, Radhashree ; Goel, Sanjay

Oncotarget, 2019-09, Vol.10 (53), p.5510-5522

United States: Impact Journals LLC

Texto completo disponível